Reference
Singh SM, et al. An Economic Evaluation of Percutaneous Left Atrial Appendage Occlusion: Dabigatran and Warfarin for Stroke Prevention in Patients with Non-Valvular Atrial Fibrillation. Circulation : 22 May 2013. Available from: URL: http://dx.doi.org/10.1161/CIRCULATIONAHA.112.000920
Rights and permissions
About this article
Cite this article
New therapies value for money in atrial fibrillation. PharmacoEcon Outcomes News 681, 6 (2013). https://doi.org/10.1007/s40274-013-0506-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-013-0506-3